+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet-based), By Application (Medical, Dental, Biosensors, Bioinks), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 109 Pages
  • April 2023
  • Region: Global
  • Grand View Research
  • ID: 4538801
The global 3D bioprinting market size is expected to reach USD 5.3 billion by 2030, expanding at a CAGR of 12.5% over the forecast period. Rising cases of COVID-19 and high prevalence of chronic diseases are some of the major factors contributing to the growth. During the outbreak of the pandemic, 3D printing has stepped up to become a vital technology to support improved healthcare and emergency response.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1, 956, 880 deaths, across the globe. This pandemic has fast-tracked the development of vaccine and drug testing.

In the meantime, various 3D bioprinting companies are focused on the R&D of artificial tissues. With the help of U-FAB and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator.

The pandemic not only affected the well-being of people, but also affected the economy, and various other healthcare infrastructures worldwide. It severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situations, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to healthcare workers.

North America held the highest share of about 30.9% in 2022. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness increased technological development in the pharmaceutical and biopharmaceutical sectors.

3D Bioprinting Market Report Highlights

  • The medical segment accounted for the largest share of 37.6% in 2022 due to the increasing investment made in R&D
  • The magnetic levitation segment is anticipated to witness the highest CAGR of 13.7% over the forecast period due to technological development, and increasing adoption of magnetic levitation techniques by various innovators
  • North America dominated the market in 2022 with a share of 30.9%. Growing government expenditure on the healthcare industry is one of the major factors driving the market in this region
  • Some of the key players include Organovo; Envision TEC; Inventia Life Science PTY LTD; Poietis; Vivax Bio, LLC; Allevi; Cyfuse Biomedical K.K.; 3D Bioprinting Solutions; Cellink Global; Regemat 3D S.L.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global 3D Bioprinting Market

What is the estimated value of the Global 3D Bioprinting Market?

The Global 3D Bioprinting Market was estimated to be valued at $2 Billion in 2022.

What is the growth rate of the Global 3D Bioprinting Market?

The growth rate of the Global 3D Bioprinting Market is 12.5%, with an estimated value of $5.3 Billion by 2030.

What is the forecasted size of the Global 3D Bioprinting Market?

The Global 3D Bioprinting Market is estimated to be worth $5.3 Billion by 2030.

Who are the key companies in the Global 3D Bioprinting Market?

Key companies in the Global 3D Bioprinting Market include Envisiontec, Inc., Organovo, Inventia Life Science Pty Ltd, Poietis, Vivax Bio, LLC, Allevi, Cyfuse Biomedical K.K., 3D Bioprinting Solutions, Cellink Global and Regemat 3D S.L..

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 internal database
1.3.3 Secondary technology & third party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 3D Bioprinting Market Outlook, 2018 - 2030
Chapter 3 Industry Outlook: Market Variables, Trends, & Scope
3.1 Market Segmentation and Scope
3.2 Market Size and Growth Prospects
3.3 3D Bioprinting Market: Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Technological advancement in the 3d bioprinting industry
3.3.1.2 Rising prevalence of chronic disease
3.3.1.3 Increasing use of 3d bioprinting in the pharmaceutical and cosmetology
3.3.2 Market restraint analysis
3.3.2.1 The high cost of 3D bioprinters
3.3.2.2 Lack of trained professionals
3.4 Industry Analysis - Porter’s
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Substitution Threat
3.4.4 New Entrants Threat
3.4.5 Competitive Rivalry
3.5 3D Bioprinting-SWOT Analysis, By PEST
3.5.1 Political landscape
3.5.2 Economic landscape
3.5.3 Social landscape
3.5.4 Technology landscape
3.6 Covid Impact Analysis
Chapter 4 3D Bioprinting Market: Technology Estimates & Trend Analysis
4.1 Global 3D Bioprinting Market: Technology Movement Analysis
4.2 Magnetic Levitation Technology
4.2.1 Global Magnetic Levitation technology market, 2018 - 2030 (USD Million)
4.3 Inkjet-based Technology
4.3.1 Global Inkjet-based technology market, 2018 - 2030 (USD Million)
4.4 Syringe-based Technology
4.4.1 Global Syringe-based technology market, 2018 - 2030 (USD Million)
4.5 Laser-based Technology
4.5.1 Global Laser-based technology market, 2018 - 2030 (USD Million)
4.6 Others
4.6.1 Global Other technologies market, 2018 - 2030 (USD Million)
Chapter 6 3D Bioprinting Market: Application Estimates & Trend Analysis
6.1 Global 3D Bioprinting Market: Application Movement Analysis
6.2 Medical
6.2.1 Global medical market, 2018 - 2030 (USD Million)
6.2.2 Tissue and organ generation
6.2.2.1 Global tissue and organ generation market, 2018 - 2030 (USD Million)
6.2.3 Medical pills
6.2.3.1 Global Medical pills market, 2018 - 2030 (USD Million)
6.2.4 Prosthetics and implants
6.2.4.1 Global Prosthetics and implants market, 2018 - 2030 (USD Million)
6.2.5 Others
6.2.6.1 Global others application market, 2018 - 2030 (USD Million)
6.3 Dental
6.3.1 Global dental market, 2018 - 2030 (USD Million)
6.4 Biosensors
6.4.1 Global biosensors market, 2018 - 2030 (USD Million)
6.5 Consumer/Personal Product Testing
6.5.1 Global consumer/personal product testing market, 2018 - 2030 (USD Million)
6.6 Bioinks
6.6.1 Global bioinks market, 2018 - 2030 (USD Million)
6.7 Food and Animal Product
6.7.1 Global food and animal market, 2018 - 2030 (USD Million)
Chapter 7 3D Bioprinting Market: Regional Estimates & Trend Analysis, by Service, Technology, & Application
7.1 3D Bioprinting Market Share By Region, 2022 & 2030
7.2 North America
7.2.1 North America 3D Bioprinting market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.2.2.2 U.S. 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.2.3.2 Canada 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe 3D Bioprinting market, 2018 - 2030 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.2.2 U.K. 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.3.2 Germany 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.4.2 France 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.5.2 Italy 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.6.2 Spain 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.7 Denmark
7.3.7.1 Denmark 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.7.2 Denmark 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.8 Sweden
7.3.8.1 Sweden 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.8.2 Sweden 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.3.9 Norway
7.3.9.1 Norway 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.3.9.2 Norway 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific 3D Bioprinting market, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.2.2 Japan 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 China 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.3.2 China 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.4.2 India 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4.5 Thailand
7.4.5.1 Thailand 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.5.2 Thailand 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4.6 Australia
7.4.6.1 Australia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.6.2 Australia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.4.7 South Korea
7.4.7.1 South Korea 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.4.7.2 South Korea 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America 3D Bioprinting market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.5.2.2 Brazil 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.5.3.2 Mexico 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.5.4.2 Argentina 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.5.5 Columbia
7.5.5.1 Columbia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.5.5.2 Columbia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 Middle East & Africa 3D Bioprinting market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.6.2.2 South Africa 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.6.3.2 Saudi Arabia 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.6.4.2 UAE 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
7.6.5 Kuwait
7.6.5.1 Kuwait 3D Bioprinting market, by technology, 2018 - 2030 (USD Million)
7.6.5.2 Kuwait 3D Bioprinting market, by application, 2018 - 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Envisiontec, Inc.
8.1.1.1 Company overview
8.1.1.2 Product benchmarking
8.1.1.3 Strategic initiatives
8.1.2 Organovo
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Inventia Life Science Pty Ltd
8.1.3.1 Company overview
8.1.3.2 Product benchmarking
8.1.4 POIETIS
8.1.4.1 Company overview
8.1.4.2 Product benchmarking
8.1.4.3 Strategic initiatives
8.1.5 VIVAX BIO, LLC
8.1.5.1 Company overview
8.1.5.2 Product benchmarking
8.1.5.3 Strategic initiatives
8.1.6 ALLEVI
8.1.6.1 Company overview
8.1.6.2 Product benchmarking
8.1.7 Cyfuse Biomedical K.K.
8.1.7.1 Company overview
8.1.7.2 Product benchmarking
8.1.7.3 Strategic initiatives
8.1.8 3D Bioprinting Solutions
8.1.8.1 Company overview
8.1.8.2 Product benchmarking
8.1.9 CELLINK GLOBAL
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 REGEMAT 3D S.L.
8.1.10.1 Company overview
8.1.10.2 Product benchmarking
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 3D bioprinting market snapshot (2022)
Fig. 8 Market segmentation
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Porter’s five forces analysis
Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 13 3D bioprinting market technology outlook: Segment dashboard
Fig. 14 3D bioprinting market: Technology movement analysis
Fig. 15 Magnetic levitation market, 2018 - 2030 (USD Million)
Fig. 16 Inkjet-based market, 2018 - 2030 (USD Million)
Fig. 17 Syringe-based market, 2018 - 2030 (USD Million)
Fig. 18 Laser-based market, 2018 - 2030 (USD Million)
Fig. 19 Others market, 2018 - 2030 (USD Million)
Fig. 20 3D bioprinting market application outlook: Segment dashboard
Fig. 21 3D bioprinting market: Application movement analysis
Fig. 22 Medical market, 2018 - 2030 (USD Million)
Fig. 23 Tissue and organ generation market, 2018 - 2030 (USD Million)
Fig. 24 Medical pills market, 2018 - 2030 (USD Million)
Fig. 25 Prosthetic and implants market, 2018 - 2030 (USD Million)
Fig. 26 Other medical application market, 2018 - 2030 (USD Million)
Fig. 27 Dental market, 2018 - 2030 (USD Million)
Fig. 28 Biosensors market, 2018 - 2030 (USD Million)
Fig. 29 Consumer/personal product testing market, 2018 - 2030 (USD Million)
Fig. 30 Bioinks market, 2018 - 2030 (USD Million)
Fig. 31 Food and animal product market, 2018 - 2030 (USD Million)
Fig. 32 Regional market: Key takeaways
Fig. 33 Regional outlook, 2022 & 2030
Fig. 34 North America market, 2018 - 2030 (USD Million)
Fig. 35 U.S. market, 2018 - 2030 (USD Million)
Fig. 36 Canada market, 2018 - 2030 (USD Million)
Fig. 37 Europe market, 2018 - 2030 (USD Million)
Fig. 38 U.K. market, 2018 - 2030 (USD Million)
Fig. 39 Germany market, 2018 - 2030 (USD Million)
Fig. 40 France market, 2018 - 2030 (USD Million)
Fig. 41 Italy market, 2018 - 2030 (USD Million)
Fig. 42 Spain market, 2018 - 2030 (USD Million)
Fig. 43 Denmark market, 2018 - 2030 (USD Million)
Fig. 44 Sweden market, 2018 - 2030 (USD Million)
Fig. 45 Norway market, 2018 - 2030 (USD Million)
Fig. 46 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 47 Japan market, 2018 - 2030 (USD Million)
Fig. 48 China market, 2018 - 2030 (USD Million)
Fig. 49 India market, 2018 - 2030 (USD Million)
Fig. 50 Thailand market, 2018 - 2030 (USD Million)
Fig. 51 Australia market, 2018 - 2030 (USD Million)
Fig. 52 South Korea market, 2018 - 2030 (USD Million)
Fig. 53 Latin America market, 2018 - 2030 (USD Million)
Fig. 54 Brazil market, 2018 - 2030 (USD Million)
Fig. 55 Mexico market, 2018 - 2030 (USD Million)
Fig. 56 Argentina market, 2018 - 2030 (USD Million)
Fig. 57 Colombia market, 2018 - 2030 (USD Million)
Fig. 58 MEA market, 2018 - 2030 (USD Million)
Fig. 59 South Africa market, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 61 UAE market, 2018 - 2030 (USD Million)
Fig. 62 Kuwait market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Envisiontec, Inc.
  • Organovo
  • Inventia Life Science Pty Ltd
  • Poietis
  • Vivax Bio, LLC
  • Allevi
  • Cyfuse Biomedical K.K.
  • 3D Bioprinting Solutions
  • Cellink Global
  • Regemat 3D S.L.

Methodology

Loading
LOADING...